ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized with COVID-19

Stock Information for ARCA biopharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ARCA biopharma Inc.

ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WIRE, ABIO, SWAV, MODN
Kuehn Law Encourages WIRE, ABIO, MODN, and SWAV Investors to Contact Law Firm
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, AIRC, ABIO, MODN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq - SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE - MODN), ARCA biopharma, Inc. (Nasdaq - ABIO)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, AIRC, MODN, ABIO

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.